A new lipid formulation of low dose (1200 mg) ibuprofen is non-inferior to high dose (2400 mg) standard ibuprofen capsules in managing episodic knee pain flares. (April 2017) - Bierma-Zeinstra, S.M.; Brew, J.; Wilson, R.; Conaghan, P.G.